Literature DB >> 19154518

Combined tarsal and carpal tunnel syndrome in mucolipidosis type III. A case study and review.

Izelle Smuts1, Denise Potgieter, Francois Hendrikus van der Westhuizen.   

Abstract

Mucolipidosis type III (MLIII) (MIM# 252600) is an uncommon autosomal recessive disorder that results from uridine 5'-diphosphate-N-acetylglucosamine: lysosomal hydrolase N-acetyl-1-phosphotransferase or UDP-GlcNAc 1-phosphotransferase deficiency. Clinical manifestations include developmental delay, short stature and other structural abnormalities. Less common clinical features, such as carpal tunnel syndrome, claw hand deformities, trigger fingers, and claw toes have previously been reported, but no specific association with tarsal tunnel syndrome has been reported in the literature. Tarsal tunnel syndrome is caused by entrapment of the posterior tibialis nerve in the tunnel formed by the medial malleolus of the ankle and the flexor retinaculum. It causes pain in the heel and sole of the foot as well as abnormal sensation in the distribution area of nervus tibialis posterior. In adults, the most common cause described is a ganglion. The phenomenon is rare in children and the published series are small. This case report portrays the presentation of a young girl with breath-holding spells secondary to painful bilateral tarsal tunnel syndrome and trigger fingers subsequently diagnosed with MLIII.

Entities:  

Mesh:

Year:  2009        PMID: 19154518     DOI: 10.1111/j.1749-6632.2008.03451.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Tarsal tunnel syndrome: still more opinions than evidence. Status of the art.

Authors:  Pietro Emiliano Doneddu; Daniele Coraci; Claudia Loreti; Giulia Piccinini; Luca Padua
Journal:  Neurol Sci       Date:  2017-06-29       Impact factor: 3.307

2.  Enlarged follicles and temporomandibular joint abnormalities in mucolipidosis Type III.

Authors:  H Khalifa; H S Grubisa; L Lee; E W N Lam
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

3.  Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering.

Authors:  Changsoo Kang; Sheikh Riazuddin; Jennifer Mundorff; Donna Krasnewich; Penelope Friedman; James C Mullikin; Dennis Drayna
Journal:  N Engl J Med       Date:  2010-02-10       Impact factor: 91.245

4.  Mucolipidosis type III α/β: the first characterization of this rare disease by autopsy.

Authors:  Darcy A Kerr; Vincent A Memoli; Sara S Cathey; Brent T Harris
Journal:  Arch Pathol Lab Med       Date:  2011-04       Impact factor: 5.534

Review 5.  A role for inherited metabolic deficits in persistent developmental stuttering.

Authors:  Changsoo Kang; Dennis Drayna
Journal:  Mol Genet Metab       Date:  2012-07-28       Impact factor: 4.797

6.  Lysosomal Proteome and Secretome Analysis Identifies Missorted Enzymes and Their Nondegraded Substrates in Mucolipidosis III Mouse Cells.

Authors:  Giorgia Di Lorenzo; Renata Voltolini Velho; Dominic Winter; Melanie Thelen; Shiva Ahmadi; Michaela Schweizer; Raffaella De Pace; Kerstin Cornils; Timur Alexander Yorgan; Saskia Grüb; Irm Hermans-Borgmeyer; Thorsten Schinke; Sven Müller-Loennies; Thomas Braulke; Sandra Pohl
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

7.  Mucolipidosis type III, a series of adult patients.

Authors:  Esmee Oussoren; David van Eerd; Elaine Murphy; Robin Lachmann; Jan C van der Meijden; Lies H Hoefsloot; Rob Verdijk; George J G Ruijter; Mario Maas; Carla E M Hollak; Janneke G Langendonk; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-04-27       Impact factor: 4.982

8.  Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis).

Authors:  Shao-Jia Mao; Yu-Mei Zu; Yang-Li Dai; Chao-Chun Zou
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.